During the recent session, Recursion Pharmaceuticals Inc (NASDAQ:RXRX)’s traded shares were 4.64 million, with the beta value of the company hitting 0.87. At the last
In the last trading session, 25.39 million shares of the Recursion Pharmaceuticals Inc (NASDAQ:RXRX) were traded, and its beta was 0.84. Most recently the company’s
In the last trading session, 35.42 million shares of the Recursion Pharmaceuticals Inc (NASDAQ:RXRX) were traded, and its beta was 0.82. Most recently the company’s
Recursion Pharmaceuticals Inc (NASDAQ:RXRX)’s traded shares stood at 25.3 million during the last session, with the company’s beta value hitting 0.82. At the close of
In the last trading session, 28.39 million Recursion Pharmaceuticals Inc (NASDAQ:RXRX) shares changed hands as the company’s beta touched 0.82. With the company’s per share
In the last trading session, 31.22 million Recursion Pharmaceuticals Inc (NASDAQ:RXRX) shares changed hands as the company’s beta touched 0.87. With the company’s per share
In recent trading session, Recursion Pharmaceuticals Inc (NASDAQ:RXRX) saw 9.46 million shares changing hands at last check today with its beta currently measuring 0.87. Company’s
Recursion Pharmaceuticals Inc (NASDAQ:RXRX) has a beta value of 0.87 and has seen 71.16 million shares traded in the last trading session. The company, currently
Recursion Pharmaceuticals Inc (NASDAQ:RXRX) has a beta value of 0.87 and has seen 37.94 million shares traded in the recent trading session. The company, currently
During the last session, Recursion Pharmaceuticals Inc (NASDAQ:RXRX)’s traded shares were 28.47 million, with the beta value of the company hitting 0.85. At the end
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
